Alaunos Therapeutics

TCRT

About

Alaunos Therapeutics
Alaunos Therapeutics
TCRT.US

Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc.

Profile

Company Name
Alaunos Therapeutics, Inc.
Market
NasdaqCM
Founded
Industry
--
Fiscal Year End
December 31

Related Securities

Industry

Management